VEGF in biological control

被引:162
作者
Breen, Ellen C. [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
angiogenesis; permeability; neuroprotection; apoptosis; kidney; skeletal muscle; lung;
D O I
10.1002/jcb.21579
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor A (VEGF-A) belongs to a family of heparin binding growth factors that include VEGF-B, VEGF-C, VEGF-D, and placental-like growth factor (PLGF). First discovered for its ability to regulate vascular endothelial cell permeability, VEGF is a well-known angiogenic factor that is important for vascular development and maintenance in all mammalian organs. The development of molecular tools and pharmacological agents to selectively inhibit VEGF function and block angiogenesis and/or vascular permeability has led to great promise in the treatment of various cancers, macular degeneration, and wound healing. However, VEGF is also important in animals for the regulation of angiogenesis, stem cell and monocyte/macrophage recruitment, maintenance of kidney and lung barrier functions and neuroprotection. In addition to its role in regulating endothelial cell proliferation, migration, and cell survival, VEGF receptors are also located on many non-endothelial cells and act through autrocrine pathways to regulate cell survival and function. The following review will discuss the role of VEGF in physiological angiogenesis as well as its role in non-angiogenic processes that take place in adult organs.J. Cell. Biochem. 102: 1358-1367, 2007. (c) 2007 Wiley-Liss, Inc.
引用
收藏
页码:1358 / 1367
页数:10
相关论文
共 55 条
[11]   Loss of HIF-2 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice [J].
Compernolle, V ;
Brusselmans, K ;
Acker, T ;
Hoet, P ;
Tjwa, M ;
Beck, H ;
Plaisance, S ;
Dor, Y ;
Keshet, E ;
Lupu, F ;
Nemery, B ;
Dewerchin, M ;
Van Veldhoven, P ;
Plate, K ;
Moons, L ;
Collen, D ;
Carmeliet, P .
NATURE MEDICINE, 2002, 8 (07) :702-710
[12]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[13]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[14]   ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS [J].
FOLKMAN, J ;
MERLER, E ;
ABERNATHY, C ;
WILLIAMS, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (02) :275-+
[15]   ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM [J].
FONG, GH ;
ROSSANT, J ;
GERTSENSTEIN, M ;
BREITMAN, ML .
NATURE, 1995, 376 (6535) :66-70
[16]   Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes [J].
Foster, RR ;
Hole, R ;
Anderson, K ;
Satchell, SC ;
Coward, RJ ;
Mathieson, PW ;
Gillatt, DA ;
Saleem, MA ;
Bates, DO ;
Harper, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (06) :F1263-F1273
[17]   Innate immunity and angiogenesis [J].
Frantz, S ;
Vincent, KA ;
Feron, O ;
Kelly, RA .
CIRCULATION RESEARCH, 2005, 96 (01) :15-26
[18]   Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development [J].
Gale, NW ;
Dominguez, MG ;
Noguera, I ;
Pan, L ;
Hughes, V ;
Valenzuela, DM ;
Murphy, AJ ;
Adams, NC ;
Lin, HC ;
Holash, J ;
Thurston, G ;
Yancopoulos, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) :15949-15954
[19]  
Gerber HP, 1999, DEVELOPMENT, V126, P1149
[20]   Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation [J].
Gerber, HP ;
McMurtrey, A ;
Kowalski, J ;
Yan, MH ;
Keyt, BA ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30336-30343